Newsroom

On Wednesday 9 March, a TB-focused webinar was organized for partners of the AMR Accelerator. The session started with an update from UNITE4TB, presented by Michael Hoelscher, Scientific Coordinator of UNITE4TB and Director of Tropical Medicine and Infectious Diseases at LMU, University of Munich.  

The UNITE4TB Community Advisory Group (CAG), which has been established to represent the views of the TB community at all stages of the project, met for the first time on Wednesday 16 February.

Registration is now open for the first UNITE4TB webinar focusing on the global burden of Tuberculosis (TB).

In a recent interview for the IMI AMR Accelerator Newsletter, UNITE4TB Project Coordinator, Martin Boeree from Radboud University Medical Centre, spoke about the key objectives of the project and how work has progressed in these first six months.

The increasing clinical and public health challenge of multidrug-resistant TB has triggered renewed scientific activity in anti-TB drug development.

UNITE4TB, a new consortium of 30 partners from 13 countries, has officially launched.